Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11905 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841526501113069568 |
|---|---|
| author | Yixiao Mo Qi Zhang Miao Wang Jihui Chen Wenting Hu Changcheng Chen Yanjing Tang Zhuo Wang Jingjing Wang Xiaoxiao Chen Shuhong Shen |
| author_facet | Yixiao Mo Qi Zhang Miao Wang Jihui Chen Wenting Hu Changcheng Chen Yanjing Tang Zhuo Wang Jingjing Wang Xiaoxiao Chen Shuhong Shen |
| author_sort | Yixiao Mo |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-774d81abd3c442a58dc94d0405ee7ed6 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-774d81abd3c442a58dc94d0405ee7ed62025-01-16T19:43:57ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286882Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemiaYixiao Mo0Qi Zhang1Miao Wang2Jihui Chen3Wenting Hu4Changcheng Chen5Yanjing Tang6Zhuo Wang7Jingjing Wang8Xiaoxiao Chen9Shuhong Shen10Department of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Pediatrics, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, Henan, ChinaDepartment of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaCrown Bioscience, Inc., CA, USADepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Hematology/Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China Not available. https://haematologica.org/article/view/11905 |
| spellingShingle | Yixiao Mo Qi Zhang Miao Wang Jihui Chen Wenting Hu Changcheng Chen Yanjing Tang Zhuo Wang Jingjing Wang Xiaoxiao Chen Shuhong Shen Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia Haematologica |
| title | Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia |
| title_full | Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia |
| title_fullStr | Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia |
| title_full_unstemmed | Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia |
| title_short | Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia |
| title_sort | results from patient derived xenograft models support co administration of allopurinol and 6 mercaptopurine to reduce hepatotoxicity and improve event free survival in pediatric acute lymphoblastic leukemia |
| url | https://haematologica.org/article/view/11905 |
| work_keys_str_mv | AT yixiaomo resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT qizhang resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT miaowang resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT jihuichen resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT wentinghu resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT changchengchen resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT yanjingtang resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT zhuowang resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT jingjingwang resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT xiaoxiaochen resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia AT shuhongshen resultsfrompatientderivedxenograftmodelssupportcoadministrationofallopurinoland6mercaptopurinetoreducehepatotoxicityandimproveeventfreesurvivalinpediatricacutelymphoblasticleukemia |